Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an...
Q1 2026
May 8, 2026
FY 2025
Mar 10, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 6, 2025